Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Redmond

Showing results (51-60 of 205) with videos related to

Pageof 21
Sort By:
Cancer Immunology Research|April 30, 2014
Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunityWilliam L Redmond, Stefanie N Linch, Melissa J Kasiewicz
Cancer Immunology Research|February 17, 2021
Enhancing the Generation of Eomes<sup>hi</sup> CD8<sup>+</sup> T Cells Augments the Efficacy of OX40- and CTLA-4-Targeted ImmunotherapyDana A Emerson, Annah S Rolig, William L Redmond
Substance Use & Misuse|June 12, 2021
The Continuum of Recovery from Alcohol Dependence: From Addiction Remission to Complete Mental HealthMelissa L Redmond, Anna S Buhrmann, Esme Fuller-Thomson
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2000
Cutting edge: T cell-mediated pathology in murine Lyme borreliosisM D McKisic, W L Redmond, S W Barthold
Proceedings of the National Academy of Sciences of the United States of America|January 14, 2005
Optical forces between metallic particlesA J Hallock, P L Redmond, L E Brus
European Journal of Immunology|August 13, 2009
Ligation of the OX40 co-stimulatory receptor reverses self-Ag and tumor-induced CD8 T-cell anergy in vivoWilliam L Redmond, Michael J Gough, Andrew D Weinberg
Developmental Biology|February 15, 1997
Cues intrinsic to the spinal cord determine the pattern and timing of primary afferent growthL Redmond, H Xie, L Ziskind-Conhaim, et al.
Frontiers in Immunology|March 13, 2023
Enhancement of anti-tumor efficacy of immune checkpoint blockade by alpha-TEAWilliam L Redmond, Melissa J Kasiewicz, Emmanuel T Akporiaye
Frontiers in Oncology|March 13, 2015
OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the MetalStefanie N Linch, Michael J McNamara, William L Redmond
Journal of Immunology (Baltimore, Md. : 1950)|August 28, 2020
Intracellular Galectin-3 Is Essential for OX40-Mediated Memory CD8<sup>+</sup> T Cell DevelopmentMohammad Farhad Amani, Annah S Rolig, William L Redmond
Pageof 21

Showing results (51-60 of 205) with videos related to

Sort By:
Pageof 21
Cancer Immunology Research|April 30, 2014
Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunityWilliam L Redmond, Stefanie N Linch, Melissa J Kasiewicz
Cancer Immunology Research|February 17, 2021
Enhancing the Generation of Eomes<sup>hi</sup> CD8<sup>+</sup> T Cells Augments the Efficacy of OX40- and CTLA-4-Targeted ImmunotherapyDana A Emerson, Annah S Rolig, William L Redmond
Substance Use & Misuse|June 12, 2021
The Continuum of Recovery from Alcohol Dependence: From Addiction Remission to Complete Mental HealthMelissa L Redmond, Anna S Buhrmann, Esme Fuller-Thomson
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2000
Cutting edge: T cell-mediated pathology in murine Lyme borreliosisM D McKisic, W L Redmond, S W Barthold
Proceedings of the National Academy of Sciences of the United States of America|January 14, 2005
Optical forces between metallic particlesA J Hallock, P L Redmond, L E Brus
European Journal of Immunology|August 13, 2009
Ligation of the OX40 co-stimulatory receptor reverses self-Ag and tumor-induced CD8 T-cell anergy in vivoWilliam L Redmond, Michael J Gough, Andrew D Weinberg
Developmental Biology|February 15, 1997
Cues intrinsic to the spinal cord determine the pattern and timing of primary afferent growthL Redmond, H Xie, L Ziskind-Conhaim, et al.
Frontiers in Immunology|March 13, 2023
Enhancement of anti-tumor efficacy of immune checkpoint blockade by alpha-TEAWilliam L Redmond, Melissa J Kasiewicz, Emmanuel T Akporiaye
Frontiers in Oncology|March 13, 2015
OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the MetalStefanie N Linch, Michael J McNamara, William L Redmond
Journal of Immunology (Baltimore, Md. : 1950)|August 28, 2020
Intracellular Galectin-3 Is Essential for OX40-Mediated Memory CD8<sup>+</sup> T Cell DevelopmentMohammad Farhad Amani, Annah S Rolig, William L Redmond
Pageof 21